These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18073387)

  • 1. Exacerbations in chronic obstructive pulmonary disease: do they contribute to disease progression?
    Silverman EK
    Proc Am Thorac Soc; 2007 Dec; 4(8):586-90. PubMed ID: 18073387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts.
    Parulekar AD; Martinez C; Tsai CL; Locantore N; Atik M; Yohannes AM; Kao CC; Al-Azzawi H; Mohsin A; Wise RA; Foreman MG; Demeo DL; Regan EA; Make BJ; Boriek AM; Wiener LE; Hanania NA
    J Am Med Dir Assoc; 2017 Dec; 18(12):1063-1068. PubMed ID: 29169736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inspiratory capacity and forced expiratory volume in the first second in exacerbation of chronic obstructive pulmonary disease.
    Yetkin O; Gunen H
    Clin Respir J; 2008 Jan; 2(1):36-40. PubMed ID: 20298302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.
    Han MK; Quibrera PM; Carretta EE; Barr RG; Bleecker ER; Bowler RP; Cooper CB; Comellas A; Couper DJ; Curtis JL; Criner G; Dransfield MT; Hansel NN; Hoffman EA; Kanner RE; Krishnan JA; Martinez CH; Pirozzi CB; O'Neal WK; Rennard S; Tashkin DP; Wedzicha JA; Woodruff P; Paine R; Martinez FJ;
    Lancet Respir Med; 2017 Aug; 5(8):619-626. PubMed ID: 28668356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
    Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
    NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
    Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
    Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic obstructive pulmonary disease phenotypes: the future of COPD.
    Han MK; Agusti A; Calverley PM; Celli BR; Criner G; Curtis JL; Fabbri LM; Goldin JG; Jones PW; Macnee W; Make BJ; Rabe KF; Rennard SI; Sciurba FC; Silverman EK; Vestbo J; Washko GR; Wouters EF; Martinez FJ
    Am J Respir Crit Care Med; 2010 Sep; 182(5):598-604. PubMed ID: 20522794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 10. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.
    Donaldson GC; Seemungal TA; Bhowmik A; Wedzicha JA
    Thorax; 2002 Oct; 57(10):847-52. PubMed ID: 12324669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease.
    Tashiro H; Kurihara Y; Takahashi K; Sadamatsu H; Haraguchi T; Tajiri R; Takamori A; Kimura S; Sueoka-Aragane N
    BMC Pulm Med; 2020 Dec; 20(1):318. PubMed ID: 33287777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic obstructive pulmonary disease exacerbations and their impact on the long-term natural history of the disease].
    Dusser D
    Presse Med; 2008 Nov; 37(11):1599-603. PubMed ID: 18823740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors for COPD exacerbations and mortality in patients with overlap syndrome.
    Jaoude P; El-Solh AA
    Clin Respir J; 2019 Oct; 13(10):643-651. PubMed ID: 31436034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
    Dreyse J; Díaz O; Repetto PB; Morales A; Saldías F; Lisboa C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():525-33. PubMed ID: 25792820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent chronic obstructive pulmonary disease exacerbators: how much real, how much fictitious?
    Soler-Cataluña JJ; Rodriguez-Roisin R
    COPD; 2010 Aug; 7(4):276-84. PubMed ID: 20673037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
    Goossens LM; Nivens MC; Sachs P; Monz BU; Rutten-van Mölken MP
    Respir Med; 2011 Aug; 105(8):1195-202. PubMed ID: 21439807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural histories of chronic obstructive pulmonary disease.
    Rennard SI; Vestbo J
    Proc Am Thorac Soc; 2008 Dec; 5(9):878-83. PubMed ID: 19056710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
    Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
    Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Hospitalized Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease.
    Santibáñez M; Garrastazu R; Ruiz-Nuñez M; Helguera JM; Arenal S; Bonnardeux C; León C; García-Rivero JL
    PLoS One; 2016; 11(6):e0158727. PubMed ID: 27362765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of polymorphisms in the β2-adrenergic receptor on the susceptibility and pulmonary function of patients with chronic obstructive pulmonary disease: a meta analysis.
    Niu LM; Liang Y; Xu M; Zhang YY; Zhang Y; He B
    Chin Med J (Engl); 2012 Jun; 125(12):2213-8. PubMed ID: 22884155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.